The document proposes a new non-invasive and painless method of diagnosing diseases like cardiovascular disease and diabetes using the composition and mineralization of human saliva. The method was developed by Dr. Belskaya and has 7 invention patents. It has the advantages of early detection, simplicity, and low cost. The business plan involves commercializing the technology through partnerships with public health facilities, commercial labs, insurance companies, and individuals. An investment of $250,000 is requested to enter the estimated $19 million per year Russian diagnostics market.

1. Development of methodology for
screening of socially significant diseases
on the composition of human saliva
Author of the project:
Belskaya Lyudmila
Ph.D. in Chemistry, director

2. Product
- the technology of diagnosis on
the composition and
mineralization of a saliva
non-invasive
painless
convenient for the patient
out express
2
7 invention patents
2 know-how
Diagnosed diseases:
cardiovascular disease (coronary
heart disease, hypertension);
diabetes;
cancer screening, etc.
The advantages of the
proposed methods:
 detection of diseases at an
early (!) stage
 identification of susceptibility
to several diseases
 simplicity, accessibility and
inclusiveness methods
 does not require expensive
materials, equipment and
reagents
 do not need additional
training

3. 3
Potential customers:
1. Public health facilities
2. Commercial laboratories and
medical centers
3. Insurance companies, asking for
health insurance
4. Individuals who are watching their
health
In vitro Diagnostics (IVD)
The volume of Russian
IVD-market ~ 300 mln. $1
Diagnostics market in Russia
The estimated
market share of 2-3%
1
BioMerieux

4. 4
The population of the RF 143 million people
Projected demand of 2-3%
Potential customers 3,575,000
Frequency of survey 1 every 2 years
Income of 19 million $ per year
Profit 8,5 million $ per year
Commercial
laboratories and
medical centers
Public health
facilities
Insurance
companies
10 $
Individuals
IVD
laboratory
15 $
20 $
Cost 5$
Business model

5. The project team
5
Titov Andrey - Ph.D.,
head of the technical
direction of the
project
Belskaya Lyudmila -
Ph.D., director,
founder of the project,
part-time Chief
Accountant
Sarf Elena - Research
Engineer
+ Berdnikov Valeriy - Research Assistant
+ Korshunov Andrey - the medical consultant

6. 6
The proposal to investors:
necessary investments 250 000 $
Contact:
Belskaya Lyudmila
Tel.: 8-913-641-35-77
LudaB2005@mail.ru
Risks:
the difficulty of competition in the existing market,
the need to ensure a steady flow of orders
part of the money is "frozen", as they are constantly investing in the reserve
consumables
The future is painless methods of diagnosis!

7. 6
The proposal to investors:
necessary investments 250 000 $
Contact:
Belskaya Lyudmila
Tel.: 8-913-641-35-77
LudaB2005@mail.ru
Risks:
the difficulty of competition in the existing market,
the need to ensure a steady flow of orders
part of the money is "frozen", as they are constantly investing in the reserve
consumables
The future is painless methods of diagnosis!